跳至主要内容
临床试验/NCT00703274
NCT00703274已完成2 期

Preventing Recurrence of Thromboembolic Events Through Coordinated Treatment in the District of Columbia

Georgetown University12 个研究点 分布在 1 个国家目标入组 230 人开始时间: 2008年4月最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
入组人数
230
试验地点
12
主要终点
Hemoglobin A1C Value

研究概览

简要总结

The purpose of this study is to refine and evaluate the Preventing Recurrence of Thromboembolic Events through Coordinated Treatment in the District of Columbia (PROTECT DC) intervention. PROTECT DC is a program consisting of in-hospital education coupled with community-based "stroke navigators" and is designed to reduce the rate of vascular events or death in a population of underserved individuals with stroke.

详细描述

Despite significant advances in the prevention and treatment of cerebrovascular disease in the last few decades, stroke remains the third leading cause of death and the leading cause of adult disability in the United States. For the population that has experienced a cerebrovascular event, the risk of future stroke is greatly increased. The initiation of effective secondary prevention strategies is most effective when implemented early (before disabling stroke occurs), monitored frequently, and maintained long-term after a cerebrovascular event.

The Preventing Recurrence of Thromboembolic Events through Coordinated Treatment in the District of Columbia (PROTECT DC) intervention uses stroke navigators to help people who have suffered a stroke implement secondary prevention strategies. Stroke navigators are lay persons trained to provide education on secondary prevention behavior, and trained to navigate the health and human service system. The goals are to help individuals who have had a stroke obtain the necessary services and programs to engage in secondary prevention behaviors and, ultimately, to prevent the recurrence of stroke.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age ≥ 18 years
  • Hospitalized due to ischemic stroke* or intercurrent ischemic stroke* event within the past 30 days OR Transient ischemic attack, confirmed by stroke neurologist.
  • Atherogenic etiology(large vessel, small vessel, cryptogenic with at least one stroke risk factor, or embolic stroke due to atherogenic cardiac disease) as defined by TOAST criteria.
  • Community dwelling prior to stroke
  • Resides within the District of Columbia or closely nearby (preferably within 10 miles of the DC border)
  • Expected to reside within the District of Columbia or closely nearby (preferably within 10 miles of DC border)
  • Caregiver or interested party available, if moderately or severely disabled (not required to actually reside with participant)
  • Sufficient number of collateral contacts to assure follow-up. Defined as: Preferred: at least 6 contacts; and No fewer than 3 contacts (unless approved by study PI/co-PI/co-I)
  • Judged likely to return to community setting at completion of post-acute care.

排除标准

  • Non-atherogenic cause of stroke
  • NIHSS > 20
  • Any medical condition that would limit participation in follow up assessments
  • Baseline dementia per informant report (AD8) or screening assessment (Short Blessed Memory Orientation Concentration Test)

结局指标

主要结局

Hemoglobin A1C Value

时间窗: 1 year

Low Density Lipoprotein Value

时间窗: 1 year

Systolic Blood Pressure Value

时间窗: 1 year

Pill count of antiplatelet therapy medications

时间窗: 1 year

次要结局

  • Smoking Cessation Status(1 year)
  • AHA Diet Status(1 year)
  • Exercise Status(1 year)
  • Stroke Knowledge Level(1 year)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Chelsea Kidwell, M.D.

Medical Director, Georgetown University Stroke Center

Georgetown University

研究点 (12)

Loading locations...

相似试验

Preventing Recurrence of Thromboembolic Events... | 临床试验